SCHEMBL763137

SCHEMBL763137

NC[C@@H](CC(=O)O)Cc1ccc(N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 2/20 0.43
CACNB3 P54284 1/20 0.43
CACNA1C Q13936 1/20 0.43
PGR P06401 1/20 0.43
ADRA1A P35348 1/20 0.43
HTR2B P41595 1/20 0.43
CACNA2D2 Q9NY47 1/20 0.43
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SOAT1 P35610 1/20 0.41
GABBR2 O75899 4/20 0.41
GABBR1 Q9UBS5 4/20 0.41
CPA1 P15085 2/20 0.41
CPB1 P15086 1/20 0.41
CPA3 P15088 1/20 0.41
CPB2 Q96IY4 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27565946 0.91 TDP1 (0.45) POLBSMN1; SMN2TDP1SOAT1CPA1
SCHEMBL4168904 0.85 CPA1 (0.56) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL6898209 0.80 LOXL2 (0.52) TDP1SOAT1LOXL2CYP3A4MEN1
SCHEMBL762549 0.79 LOXL2 (0.50) SMN1; SMN2TDP1LOXL2NPC1RAB9A
SCHEMBL288929 0.78 ANPEP (0.51) POLBSMN1; SMN2TDP1SOAT1CPA1
SCHEMBL27999577 0.78 ANPEP (0.51) POLBSMN1; SMN2TDP1SOAT1CPA1
SCHEMBL763169 0.78 CACNA2D1 (0.37) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL5491720 0.77 CACNA2D1 (0.36) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL11586603 0.76 CPA1 (0.70) CPA1CPB1CPA3CPB2CYP1A2
SCHEMBL15134800 0.76 NPC1 (0.46) POLBSMN1; SMN2TDP1SOAT1CPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed